This article, published in Vaccine, discusses the challenges of achieving control of meningococcal disease in low- and middle-income countries. The authors argue that in low-income countries the main challenge is a lack of sufficient epidemiological information to allow for rational decisions about vaccine introduction, and that enhanced surveillance is needed. They also assert that financial challenges predominate in middle-income countries, which could be addressed by demonstrating the cost-effectiveness of new meningococcal vaccines and through the introduction of a tiered-pricing system. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.).

Author(s): Greenwood B, Chiarot E, MacLennan CA, O'Ryan M

Published: 2012

Resource types: Peer-reviewed journal

Diseases: Meningococcus

Topics: Introduction and service delivery; Immunization financing; Disease burden and surveillance; Disease/vaccine specific information

Regions: Global